Literature DB >> 9630236

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.

M Jones1, K Olafson, M R Del Bigio, J Peeling, A Nath.   

Abstract

To determine the role of the Tat protein of the human immunodeficiency virus type 1 (HIV-1) in the pathogenesis of HIV-1 associated dementia, recombinant Tat was injected intraventricularly as a single or repeated dose into male Sprague-Dawley rats. Histopathological evaluation showed an initial infiltration of neutrophils one day after Tat injection, followed by macrophages and lymphocytes by 7 days. Tat-injected brains also exhibited astrocytosis, apoptotic cells, and ventricular enlargement 7 days following the last injection. Nuclear magnetic resonance spectroscopic analysis of tissue extracts of hippocampi from Tat-injected rats showed a decrease in the glutamate/g aminobutyric acid ratio. We conclude that the transient extracellular exposure of the central nervous system to Tat protein of HIV can cause a cascade of events leading to the influx of inflammatory cells, glial cell activation, and neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630236     DOI: 10.1097/00005072-199806000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  73 in total

1.  Acceleration of HIV dementia with methamphetamine and cocaine.

Authors:  A Nath; W F Maragos; M J Avison; F A Schmitt; J R Berger
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.

Authors:  Kylene Kehn-Hall; Irene Guendel; Lawrence Carpio; Leandros Skaltsounis; Laurent Meijer; Lena Al-Harthi; Joseph P Steiner; Avindra Nath; Olaf Kutsch; Fatah Kashanchi
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

3.  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.

Authors:  Jenna M Puccini; Daniel F Marker; Tim Fitzgerald; Justin Barbieri; Christopher S Kim; Patrick Miller-Rhodes; Shao-Ming Lu; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

4.  Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

Authors:  Yongbo Yang; Jianguo Wu; Yuanan Lu
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

5.  A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.

Authors:  Jonathan D Raybuck; Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

6.  Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.

Authors:  Xiaojuan Liu; Malabendu Jana; Subhajit Dasgupta; Sreenivas Koka; Jun He; Charles Wood; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

7.  Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.

Authors:  Jessica Lapierre; Myosotys Rodriguez; Chet Raj Ojha; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2018-05-11       Impact factor: 4.147

Review 8.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

9.  Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Authors:  Erinn S Raborn; Guy A Cabral
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030

10.  Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice.

Authors:  Elona Rrapo; Yuyan Zhu; Jun Tian; Huayan Hou; Adam Smith; Francisco Fernandez; Jun Tan; Brian Giunta
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.